 | • レポートコード：MRC2102QY15450 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、142ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界の腫瘍壊死因子受容体スーパーファミリーメンバー18市場について種類別（AMG-228、BMS-986156、FPA-154、GWN-323、INCAGN-1876、その他）、用途別（黒色腫、非小細胞肺がん、胃がん、血液がん、その他）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・腫瘍壊死因子受容体スーパーファミリーメンバー18市場の概要 ・世界の主要地域別腫瘍壊死因子受容体スーパーファミリーメンバー18市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の腫瘍壊死因子受容体スーパーファミリーメンバー18市場規模2015-2026：種類別（AMG-228、BMS-986156、FPA-154、GWN-323、INCAGN-1876、その他） ・世界の腫瘍壊死因子受容体スーパーファミリーメンバー18市場規模2015-2026：用途別（黒色腫、非小細胞肺がん、胃がん、血液がん、その他） ・腫瘍壊死因子受容体スーパーファミリーメンバー18の米国市場規模2015-2020 ・腫瘍壊死因子受容体スーパーファミリーメンバー18のヨーロッパ市場規模2015-2020 ・腫瘍壊死因子受容体スーパーファミリーメンバー18の中国市場規模2015-2020 ・腫瘍壊死因子受容体スーパーファミリーメンバー18の日本市場規模2015-2020 ・腫瘍壊死因子受容体スーパーファミリーメンバー18の東南アジア市場規模2015-2020 ・腫瘍壊死因子受容体スーパーファミリーメンバー18のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・腫瘍壊死因子受容体スーパーファミリーメンバー18の製造コスト分析 ・販売チャネル、流通業者、顧客 ・腫瘍壊死因子受容体スーパーファミリーメンバー18の市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market
The global Tumor Necrosis Factor Receptor Superfamily Member 18 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Tumor Necrosis Factor Receptor Superfamily Member 18 Scope and Market Size
The global Tumor Necrosis Factor Receptor Superfamily Member 18 market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Tumor Necrosis Factor Receptor Superfamily Member 18 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Tumor Necrosis Factor Receptor Superfamily Member 18 market is segmented into
AMG-228
BMS-986156
FPA-154
GWN-323
INCAGN-1876
Others
Segment by Application, the Tumor Necrosis Factor Receptor Superfamily Member 18 market is segmented into
Melanoma
Non-Small Cell Lung Cancer
Gastric Cancer
Blood Cancer
Others
The Tumor Necrosis Factor Receptor Superfamily Member 18 market is analysed and market size information is provided by regions (countries). Segment by Application, the Tumor Necrosis Factor Receptor Superfamily Member 18 market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Tumor Necrosis Factor Receptor Superfamily Member 18 Market Share Analysis
Tumor Necrosis Factor Receptor Superfamily Member 18 market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Tumor Necrosis Factor Receptor Superfamily Member 18 business, the date to enter into the Tumor Necrosis Factor Receptor Superfamily Member 18 market, Tumor Necrosis Factor Receptor Superfamily Member 18 product introduction, recent developments, etc.
The major vendors covered:
Ablynx NV
Amgen Inc
Apogenix GmbH
Bristol-Myers Squibb Company
Five Prime Therapeutics Inc
Incyte Corp
MedImmune LLC
Merck & Co Inc
Novartis AG
OncoMed Pharmaceuticals Inc
Regeneron Pharmaceuticals Inc
1 Tumor Necrosis Factor Receptor Superfamily Member 18 Market Overview
1.1 Tumor Necrosis Factor Receptor Superfamily Member 18 Product Scope
1.2 Tumor Necrosis Factor Receptor Superfamily Member 18 Segment by Type
1.2.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Type (2020-2026)
1.2.2 AMG-228
1.2.3 BMS-986156
1.2.4 FPA-154
1.2.5 GWN-323
1.2.6 INCAGN-1876
1.2.7 Others
1.3 Tumor Necrosis Factor Receptor Superfamily Member 18 Segment by Application
1.3.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Comparison by Application (2020-2026)
1.3.2 Melanoma
1.3.3 Non-Small Cell Lung Cancer
1.3.4 Gastric Cancer
1.3.5 Blood Cancer
1.3.6 Others
1.4 Tumor Necrosis Factor Receptor Superfamily Member 18 Market Estimates and Forecasts (2015-2026)
1.4.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Growth Rate (2015-2026)
1.4.2 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue and Growth Rate (2015-2026)
1.4.3 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Price Trends (2015-2026)
2 Tumor Necrosis Factor Receptor Superfamily Member 18 Estimate and Forecast by Region
2.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Region (2015-2020)
2.2.2 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share by Region (2015-2020)
2.3 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Tumor Necrosis Factor Receptor Superfamily Member 18 Estimates and Projections (2015-2026)
2.4.2 Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Estimates and Projections (2015-2026)
2.4.3 China Tumor Necrosis Factor Receptor Superfamily Member 18 Estimates and Projections (2015-2026)
2.4.4 Japan Tumor Necrosis Factor Receptor Superfamily Member 18 Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Tumor Necrosis Factor Receptor Superfamily Member 18 Estimates and Projections (2015-2026)
2.4.6 India Tumor Necrosis Factor Receptor Superfamily Member 18 Estimates and Projections (2015-2026)
3 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Competition Landscape by Players
3.1 Global Top Tumor Necrosis Factor Receptor Superfamily Member 18 Players by Sales (2015-2020)
3.2 Global Top Tumor Necrosis Factor Receptor Superfamily Member 18 Players by Revenue (2015-2020)
3.3 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tumor Necrosis Factor Receptor Superfamily Member 18 as of 2019)
3.4 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Average Price by Company (2015-2020)
3.5 Manufacturers Tumor Necrosis Factor Receptor Superfamily Member 18 Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Tumor Necrosis Factor Receptor Superfamily Member 18 Players (Opinion Leaders)
4 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size by Type
4.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Historic Market Review by Type (2015-2020)
4.1.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Type (2015-2020)
4.1.2 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share by Type (2015-2020)
4.1.3 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Price by Type (2015-2020)
4.2 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Forecast by Type (2021-2026)
4.2.2 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Forecast by Type (2021-2026)
4.2.3 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Price Forecast by Type (2021-2026)
5 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size by Application
5.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Historic Market Review by Application (2015-2020)
5.1.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Application (2015-2020)
5.1.2 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share by Application (2015-2020)
5.1.3 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Price by Application (2015-2020)
5.2 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Forecast by Application (2021-2026)
5.2.2 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Forecast by Application (2021-2026)
5.2.3 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Price Forecast by Application (2021-2026)
6 United States Tumor Necrosis Factor Receptor Superfamily Member 18 Market Facts & Figures
6.1 United States Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Company (2015-2020)
6.2 United States Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Type (2015-2020)
6.3 United States Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Application (2015-2020)
7 Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Market Facts & Figures
7.1 Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Company (2015-2020)
7.2 Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Type (2015-2020)
7.3 Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Application (2015-2020)
8 China Tumor Necrosis Factor Receptor Superfamily Member 18 Market Facts & Figures
8.1 China Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Company (2015-2020)
8.2 China Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Type (2015-2020)
8.3 China Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Application (2015-2020)
9 Japan Tumor Necrosis Factor Receptor Superfamily Member 18 Market Facts & Figures
9.1 Japan Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Company (3015-3030)
9.2 Japan Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Type (2015-2020)
9.3 Japan Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Application (2015-2020)
10 Southeast Asia Tumor Necrosis Factor Receptor Superfamily Member 18 Market Facts & Figures
10.1 Southeast Asia Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Application (2015-2020)
11 India Tumor Necrosis Factor Receptor Superfamily Member 18 Market Facts & Figures
11.1 India Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Company (2015-2020)
11.2 India Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Type (2015-2020)
11.3 India Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Tumor Necrosis Factor Receptor Superfamily Member 18 Business
12.1 Ablynx NV
12.1.1 Ablynx NV Corporation Information
12.1.2 Ablynx NV Business Overview
12.1.3 Ablynx NV Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Ablynx NV Tumor Necrosis Factor Receptor Superfamily Member 18 Products Offered
12.1.5 Ablynx NV Recent Development
12.2 Amgen Inc
12.2.1 Amgen Inc Corporation Information
12.2.2 Amgen Inc Business Overview
12.2.3 Amgen Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Amgen Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Products Offered
12.2.5 Amgen Inc Recent Development
12.3 Apogenix GmbH
12.3.1 Apogenix GmbH Corporation Information
12.3.2 Apogenix GmbH Business Overview
12.3.3 Apogenix GmbH Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Apogenix GmbH Tumor Necrosis Factor Receptor Superfamily Member 18 Products Offered
12.3.5 Apogenix GmbH Recent Development
12.4 Bristol-Myers Squibb Company
12.4.1 Bristol-Myers Squibb Company Corporation Information
12.4.2 Bristol-Myers Squibb Company Business Overview
12.4.3 Bristol-Myers Squibb Company Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Bristol-Myers Squibb Company Tumor Necrosis Factor Receptor Superfamily Member 18 Products Offered
12.4.5 Bristol-Myers Squibb Company Recent Development
12.5 Five Prime Therapeutics Inc
12.5.1 Five Prime Therapeutics Inc Corporation Information
12.5.2 Five Prime Therapeutics Inc Business Overview
12.5.3 Five Prime Therapeutics Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Five Prime Therapeutics Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Products Offered
12.5.5 Five Prime Therapeutics Inc Recent Development
12.6 Incyte Corp
12.6.1 Incyte Corp Corporation Information
12.6.2 Incyte Corp Business Overview
12.6.3 Incyte Corp Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Incyte Corp Tumor Necrosis Factor Receptor Superfamily Member 18 Products Offered
12.6.5 Incyte Corp Recent Development
12.7 MedImmune LLC
12.7.1 MedImmune LLC Corporation Information
12.7.2 MedImmune LLC Business Overview
12.7.3 MedImmune LLC Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, Revenue and Gross Margin (2015-2020)
12.7.4 MedImmune LLC Tumor Necrosis Factor Receptor Superfamily Member 18 Products Offered
12.7.5 MedImmune LLC Recent Development
12.8 Merck & Co Inc
12.8.1 Merck & Co Inc Corporation Information
12.8.2 Merck & Co Inc Business Overview
12.8.3 Merck & Co Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Merck & Co Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Products Offered
12.8.5 Merck & Co Inc Recent Development
12.9 Novartis AG
12.9.1 Novartis AG Corporation Information
12.9.2 Novartis AG Business Overview
12.9.3 Novartis AG Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Novartis AG Tumor Necrosis Factor Receptor Superfamily Member 18 Products Offered
12.9.5 Novartis AG Recent Development
12.10 OncoMed Pharmaceuticals Inc
12.10.1 OncoMed Pharmaceuticals Inc Corporation Information
12.10.2 OncoMed Pharmaceuticals Inc Business Overview
12.10.3 OncoMed Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, Revenue and Gross Margin (2015-2020)
12.10.4 OncoMed Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Products Offered
12.10.5 OncoMed Pharmaceuticals Inc Recent Development
12.11 Regeneron Pharmaceuticals Inc
12.11.1 Regeneron Pharmaceuticals Inc Corporation Information
12.11.2 Regeneron Pharmaceuticals Inc Business Overview
12.11.3 Regeneron Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Regeneron Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Products Offered
12.11.5 Regeneron Pharmaceuticals Inc Recent Development
13 Tumor Necrosis Factor Receptor Superfamily Member 18 Manufacturing Cost Analysis
13.1 Tumor Necrosis Factor Receptor Superfamily Member 18 Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Tumor Necrosis Factor Receptor Superfamily Member 18
13.4 Tumor Necrosis Factor Receptor Superfamily Member 18 Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Tumor Necrosis Factor Receptor Superfamily Member 18 Distributors List
14.3 Tumor Necrosis Factor Receptor Superfamily Member 18 Customers
15 Market Dynamics
15.1 Tumor Necrosis Factor Receptor Superfamily Member 18 Market Trends
15.2 Tumor Necrosis Factor Receptor Superfamily Member 18 Opportunities and Drivers
15.3 Tumor Necrosis Factor Receptor Superfamily Member 18 Market Challenges
15.4 Tumor Necrosis Factor Receptor Superfamily Member 18 Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs) by Region (2015-2020)
Table 5. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Region (2015-2020)
Table 6. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Share by Region (2015-2020)
Table 8. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs) Forecast by Region (2021-2026)
Table 9. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Share Forecast by Region (2021-2026)
Table 12. Global Tumor Necrosis Factor Receptor Superfamily Member 18 (K Pcs) of Key Companies (2015-2020)
Table 13. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Share by Company (2015-2020)
Table 14. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Share by Company (2015-2020)
Table 16. Global Tumor Necrosis Factor Receptor Superfamily Member 18 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tumor Necrosis Factor Receptor Superfamily Member 18 as of 2019)
Table 17. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Average Price (USD/Pcs) of Key Company (2015-2020)
Table 18. Manufacturers Tumor Necrosis Factor Receptor Superfamily Member 18 Manufacturing Sites and Area Served
Table 19. Manufacturers Tumor Necrosis Factor Receptor Superfamily Member 18 Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Tumor Necrosis Factor Receptor Superfamily Member 18 Players
Table 22. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs) by Type (2015-2020)
Table 23. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Share by Type (2015-2020)
Table 24. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Price (K Pcs) by Type (2015-2020)
Table 26. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Share by Type (2021-2026)
Table 27. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Share by Type (2021-2026)
Table 29. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Price (K Pcs) by Type (2021-2026)
Table 30. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs) by Application (2015-2020)
Table 31. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Share by Application (2015-2020)
Table 32. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Price (K Pcs) by Application (2015-2020)
Table 34. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs) by Application (2021-2026)
Table 35. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Share by Application (2021-2026)
Table 36. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Share by Application (2021-2026)
Table 38. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Price (K Pcs) by Application (2021-2026)
Table 39. United States Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs) by Company (2015-2020)
Table 40. United States Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Company (2015-2020)
Table 41. United States Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs) by Type (2015-2020)
Table 42. United States Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Type (2015-2020)
Table 43. United States Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs) by Application (2015-2020)
Table 44. United States Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Application (2015-2020)
Table 45. Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs) by Company (2015-2020)
Table 46. Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Company (2015-2020)
Table 47. Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs) by Type (2015-2020)
Table 48. Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Type (2015-2020)
Table 49. Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs) by Application (2015-2020)
Table 50. Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Type (2015-2020)
Table 51. China Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs) by Company (2015-2020)
Table 52. China Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Company (2015-2020)
Table 53. China Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs) by Type (2015-2020)
Table 54. China Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Type (2015-2020)
Table 55. China Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs) by Application (2015-2020)
Table 56. China Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Application (2015-2020)
Table 57. Japan Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs) by Company (2015-2020)
Table 58. Japan Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Company (2015-2020)
Table 59. Japan Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs) by Type (2015-2020)
Table 60. Japan Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Type (2015-2020)
Table 61. Japan Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs) by Application (2015-2020)
Table 62. Japan Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs) by Company (2015-2020)
Table 64. Southeast Asia Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs) by Type (2015-2020)
Table 66. Southeast Asia Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs) by Type (2015-2020)
Table 68. Southeast Asia Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Application (2015-2020)
Table 69. India Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs) by Company (2015-2020)
Table 70. India Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Company (2015-2020)
Table 71. India Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs) by Type (2015-2020)
Table 72. India Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Type (2015-2020)
Table 73. India Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs) by Application (2015-2020)
Table 74. India Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Application (2015-2020)
Table 75. Ablynx NV Corporation Information
Table 76. Ablynx NV Description and Business Overview
Table 77. Ablynx NV Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 78. Ablynx NV Tumor Necrosis Factor Receptor Superfamily Member 18 Product
Table 79. Ablynx NV Recent Development
Table 80. Amgen Inc Corporation Information
Table 81. Amgen Inc Description and Business Overview
Table 82. Amgen Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. Amgen Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Product
Table 84. Amgen Inc Recent Development
Table 85. Apogenix GmbH Corporation Information
Table 86. Apogenix GmbH Description and Business Overview
Table 87. Apogenix GmbH Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. Apogenix GmbH Tumor Necrosis Factor Receptor Superfamily Member 18 Product
Table 89. Apogenix GmbH Recent Development
Table 90. Bristol-Myers Squibb Company Corporation Information
Table 91. Bristol-Myers Squibb Company Description and Business Overview
Table 92. Bristol-Myers Squibb Company Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. Bristol-Myers Squibb Company Tumor Necrosis Factor Receptor Superfamily Member 18 Product
Table 94. Bristol-Myers Squibb Company Recent Development
Table 95. Five Prime Therapeutics Inc Corporation Information
Table 96. Five Prime Therapeutics Inc Description and Business Overview
Table 97. Five Prime Therapeutics Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 98. Five Prime Therapeutics Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Product
Table 99. Five Prime Therapeutics Inc Recent Development
Table 100. Incyte Corp Corporation Information
Table 101. Incyte Corp Description and Business Overview
Table 102. Incyte Corp Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 103. Incyte Corp Tumor Necrosis Factor Receptor Superfamily Member 18 Product
Table 104. Incyte Corp Recent Development
Table 105. MedImmune LLC Corporation Information
Table 106. MedImmune LLC Description and Business Overview
Table 107. MedImmune LLC Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 108. MedImmune LLC Tumor Necrosis Factor Receptor Superfamily Member 18 Product
Table 109. MedImmune LLC Recent Development
Table 110. Merck & Co Inc Corporation Information
Table 111. Merck & Co Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 112. Merck & Co Inc Description and Business Overview
Table 113. Merck & Co Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Product
Table 114. Merck & Co Inc Recent Development
Table 115. Novartis AG Corporation Information
Table 116. Novartis AG Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 117. Novartis AG Description and Business Overview
Table 118. Novartis AG Tumor Necrosis Factor Receptor Superfamily Member 18 Product
Table 119. Novartis AG Recent Development
Table 120. OncoMed Pharmaceuticals Inc Corporation Information
Table 121. OncoMed Pharmaceuticals Inc Description and Business Overview
Table 122. OncoMed Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 123. OncoMed Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Product
Table 124. OncoMed Pharmaceuticals Inc Recent Development
Table 125. Regeneron Pharmaceuticals Inc Corporation Information
Table 126. Regeneron Pharmaceuticals Inc Description and Business Overview
Table 127. Regeneron Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 128. Regeneron Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Product
Table 129. Regeneron Pharmaceuticals Inc Recent Development
Table 130. Production Base and Market Concentration Rate of Raw Material
Table 131. Key Suppliers of Raw Materials
Table 132. Tumor Necrosis Factor Receptor Superfamily Member 18 Distributors List
Table 133. Tumor Necrosis Factor Receptor Superfamily Member 18 Customers List
Table 134. Tumor Necrosis Factor Receptor Superfamily Member 18 Market Key Trends
Table 135. Tumor Necrosis Factor Receptor Superfamily Member 18 Key Opportunities and Drivers
Table 136. Tumor Necrosis Factor Receptor Superfamily Member 18 Market Challenges
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Tumor Necrosis Factor Receptor Superfamily Member 18 Product Picture
Figure 2. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Share by Application in 2020 & 2026
Figure 6. Melanoma Examples
Figure 7. Non-Small Cell Lung Cancer Examples
Figure 8. Gastric Cancer Examples
Figure 9. Blood Cancer Examples
Figure 10. Others Examples
Figure 11. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs) Growth Rate (2015-2026)
Figure 12. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue (US$ Million) Growth Rate (2015-2026)
Figure 13. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Price Trends Growth Rate (2015-2026) (USD/Pcs)
Figure 14. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share by Region: 2015 VS 2020
Figure 15. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share by Region: 2021 VS 2026
Figure 16. United States Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. United States Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs) Growth Rate (2015-2026)
Figure 18. Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (Million USD) Growth Rate (2015-2026)
Figure 20. China Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. China Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (Million USD) and Growth Rate (2015-2026)
Figure 22. Japan Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Japan Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. Southeast Asia Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (Million USD) Growth Rate (2015-2026)
Figure 26. India Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue (Million USD) Growth Rate (2015-2026)
Figure 27. India Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (Million USD) Growth Rate (2015-2026)
Figure 28. Global 5 Largest Tumor Necrosis Factor Receptor Superfamily Member 18 Players Market Share by Revenue in Tumor Necrosis Factor Receptor Superfamily Member 18 2015 & 2019
Figure 29. Tumor Necrosis Factor Receptor Superfamily Member 18 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 30. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Share by Type (2015-2020)
Figure 31. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Growth Rate by Type in 2015 & 2019
Figure 32. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Share by Application (2015-2020)
Figure 33. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Growth Rate by Application in 2015 & 2019
Figure 34. United States Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Type in 2019
Figure 35. United States Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Type in 2019
Figure 36. Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Company in 2019
Figure 37. Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Type in 2019
Figure 38. Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Application in 2019
Figure 39. China Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Company in 2019
Figure 40. China Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Type in 2019
Figure 41. China Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Application in 2019
Figure 42. Japan Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Company in 2019
Figure 43. Japan Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Type in 2019
Figure 44. Japan Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Application in 2019
Figure 45. Southeast Asia Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Company in 2019
Figure 46. Southeast Asia Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Type in 2019
Figure 47. Southeast Asia Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Application in 2019
Figure 48. India Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Company in 2019
Figure 49. India Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Type in 2019
Figure 50. India Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Application in 2019
Figure 51. Key Raw Materials Price Trend
Figure 52. Manufacturing Cost Structure of Tumor Necrosis Factor Receptor Superfamily Member 18
Figure 53. Manufacturing Process Analysis of Tumor Necrosis Factor Receptor Superfamily Member 18
Figure 54. Tumor Necrosis Factor Receptor Superfamily Member 18 Industrial Chain Analysis
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. Porter's Five Forces Analysis
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
ヒト凝固因子VIIの世界市場レポート2020 Human Coagulation Factor VII is one of the proteins that cause blood to clot in the coagulation cascade. It is an enzyme of the serine protease class. It is sometimes used unlicensed in severe uncontrollable bleeding, although there have been safety concerns. A bio similar form of recombinant activa…- 細胞性腫瘍抗体P53の世界市場レポート2020 Market Analysis and Insights: Global Cellular Tumor Antigen p53 Market The global Cellular Tumor Antigen p53 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Cellular Tumor Antigen p53 Scope and Market Size The global Ce…
- 凝固因子濃縮物の世界市場レポート2020 Market Analysis and Insights: Global Coagulation Factor Concentrate Market The global Coagulation Factor Concentrate market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Coagulation Factor Concentrate Scope and Market Size T…
- 凝固因子の世界市場レポート2020 Coagulation factors are various protein components involved in blood coagulation. Its physiological function is to be activated when blood vessels bleed, stick to platelets and plug leaks in blood vessels. Market Analysis and Insights: Global Clotting Factor Market The global Clotting Factor market …
- 非定型ケモカイン受容体3の世界市場レポート2020 Market Analysis and Insights: Global Atypical Chemokine Receptor 3 Market The global Atypical Chemokine Receptor 3 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Atypical Chemokine Receptor 3 Scope and Market Size The …